Alexander Chiu, MD, MBA, FACEP

Chief Executive Officer

Dr. Chiu developed the concepts of the new healthcare structure and founded the Air Visits family of companies. He is the principal inventor of the 911 emergency patents issued in the United States and Europe, the RMM™ and COTTER® monitoring platforms, AIR® Visits population health command center, and other intellectual property. He runs the development and FDA regulatory team for the CardiacLinx® platform, oversees evidence-based clinical operations, and leads a passionate team providing direct patient care. He heads up the advocacy group to write resolutions and guidelines for U.S. and international medical organizations and help introduce bills in both state and federal legislatures on the topics of emergencies, telemedicine, and virtual patient safety.

Dr. Chiu is the past Chairman of the Technology SIG for the American Telemedicine Association, Counselor of the Telehealth Section at the American College of Emergency Physicians, and Founder and Executive Director of the not-for-profit organization The Ross Health Foundation, a group of doctors and logisticians dedicated to the fundraising and implementation efforts for international medical missions. Previously, he designed robotics at the Stanford Genome Technology Center for high throughput gene deletion and was a synthetic chemist at Celera designing anti-cancer drugs. He received an MD from SUNY Downstate College of Medicine in Brooklyn, NY, an MBA from the University of Southern California Marshall School of Business, and a BS in Chemistry from the University of California, Santa Barbara. He completed his Emergency Medicine specialty training at the University of Medicine and Dentistry of New Jersey, University Hospital, a Level 1 trauma and cardiac center, and is a board certified diplomate of the American Board of Emergency Medicine.

Alexander Chiu, MD, MBA, FACEP